CEDIA Opiate Assay (UDI 10016429)
Manufactured by Microgenics Corporation
Device Regulatory Overview
The CEDIA Opiate Assay (Model/Catalog Number: 10016429) is a medical device manufactured by Microgenics Corporation. This product is indexed under FDA Product Code / Category Classification DJG within international Unique Device Identification (UDI) compliance databases.
Enforcement actions are currently active for this product line.
QMS Tacrolimus Immunoassay REF 10015573 CALIBRATOR SET QMS TACROLIMUS CAL A 10015566-3 QMS TACROLIMUS CAL B 10015567-3 QMS TACROLIMUS C...
Thermo Scientific MAS Bilirubin for Siemens and Dimension Vista Systems, , Product is manufactured and distributed by Microgenics Corporatio...
Thermo Scientific MAS Omni IMMUNE and Omni IMMUNE PRO; Liquid Assayed Integrated Immunoassay Control. Intended for use as an assayed con...
Technical Specifications
- Model Number
- 10016429
- Product Code / EMDN
- DJG
- Device Name
- Database Sync Date
- 2026-08-09 09:45:39
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of CEDIA Opiate Assay?
The registered manufacturer of record for CEDIA Opiate Assay is Microgenics Corporation.
What is the Primary UDI-DI identifier for CEDIA Opiate Assay?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 10016429.
What classification code is assigned to this device?
This device is registered under product classification code DJG.
Similar Classification Devices (DJG)
Other Devices by Microgenics Corporation
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint